BMD-1341

Afro_Vacancy

Senior Member
My Regimen
Reaction score
11,938
They're in the efficacy testing phase, what does that mean?

Is that meaning that a proof of concept study is underway right now with patients currently in placebo and drug taking groups?
 

distracted

Established Member
Reaction score
141
Here's their patent:
http://www.google.com/patents/US9062300

No mention of androgenic alopecia of course.

- - - Updated - - -

My bad, that's for BMD-2341

- - - Updated - - -

Quote from the CEO

“While we have not performed any tests on models of androgenic alopecia, we are hopeful that we can develop BMD-2341 for that indication in the future. The mechanism by which we believe BMD-2341 works is by stimulating the hair follicles into the anagen growth phase via beta-catenin. Androgens have been shown to inhibit beta-catenin, so we are hopeful we could overcome that inhibition. We will certainly keep the community aware of our progress and hopefully will be able to help patients in the coming years.”

Article on Folliclethought:
http://www.folliclethought.com/biologicsmd-receives-patent-for-treating-hair-loss/
 

Pavi

Senior Member
My Regimen
Reaction score
621
Just another angle to attack Androgenetic Alopecia from (if it works)
 

Henkie22

New Member
Reaction score
0
This probably will work. This sounds like it's similar to platelet therapy for hair. They can regrow hair back
from plasma, this is currently done in New York and Florida has a clinic as well.

They might have perfected it even more. If I remember correctly, GoldenMane tried this. He got lots of regrowth on the
vertex area.

But it also regrows hair on the hairline as well. And results are fast as well. Within a few weeks new hair will regrow
in the spots.

In Canada there are photos of people who did this process. Canada is very cold, so hair regrowth is not going to be
as fast as a warmer area.

Do you have a link? I would love to take a look.
 

InBeforeTheCure

Established Member
My Regimen
Reaction score
950

“While we have not performed any tests on models of androgenic alopecia, we are hopeful that we can develop BMD-2341 for that indication in the future. The mechanism by which we believe BMD-2341 works is by stimulating the hair follicles into the anagen growth phase via beta-catenin. Androgens have been shown to inhibit beta-catenin, so we are hopeful we could overcome that inhibition. We will certainly keep the community aware of our progress and hopefully will be able to help patients in the coming years.â€￾

Article on Folliclethought:
http://www.folliclethought.com/biologicsmd-receives-patent-for-treating-hair-loss/

A glorified lithium chloride, or do they have something more interesting in the works?
 
Top